Long-term outcome of treatment with intravenous cyclosporin in patients with severe ulcerative colitis.
about
Pharmacological- and non-pharmacological therapeutic approaches in inflammatory bowel disease in adultsMedical Therapy of Active Ulcerative ColitisInflammatory bowel disease: perioperative pharmacological considerations.Outcomes of rescue therapy in acute severe ulcerative colitis: data from the United Kingdom inflammatory bowel disease audit.Tacrolimus or infliximab for severe ulcerative colitis: short-term and long-term data from a retrospective observational studyMultidrug resistance gene-1 polymorphisms and resistance to cyclosporine A in patients with steroid resistant ulcerative colitis.Native valve Aspergillus endocarditis in two patients with aplastic anaemia.Hepatic complications induced by immunosuppressants and biologics in inflammatory bowel disease.European evidence-based Consensus on the management of ulcerative colitis: Current management.Toxic megacolon.Infliximab: the evidence for its place in therapy in ulcerative colitis.Strategies for the care of adults hospitalized for active ulcerative colitisGranulo-monocyto apheresis is more effective in mild ulcerative colitis than in moderate to severe disease.Pros and cons of medical management of ulcerative colitis.Tacrolimus--finally!Coadministration of cyclosporin a with prednisolone in acute interstitial pneumonia complicating polymyositis/dermatomyositis.Review article: the practical management of acute severe ulcerative colitis.Infliximab versus Cyclosporine Treatment for Severe Corticosteroid-Refractory Ulcerative Colitis: A Korean, Retrospective, Single Center Study.Methods to avoid infections in patients with inflammatory bowel disease.Review article: how and when to use ciclosporin in ulcerative colitis.Immunosuppressive drugs in ulcerative colitis: twisting facts to suit theories?Emerging biological treatments in inflammatory bowel diseases.Infliximab in ulcerative colitis.Review article: saving the colon in severe colitis - the case for medical therapy.Efficacy of infliximab in acute severe ulcerative colitis: a single-centre experience.Inflammatory bowel disease: past, present, and futureProphylaxis against Pneumocystis pneumonia in patients with inflammatory bowel disease: toward a standard of care.Adverse events associated with the use of cyclosporine in patients with inflammatory bowel disease.The use of infliximab for treatment of hospitalized patients with acute severe ulcerative colitisInfliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trialAberrant activation of nuclear factor of activated T cell 2 in lamina propria mononuclear cells in ulcerative colitis.Use of infliximab in the prevention and delay of colectomy in severe steroid dependant and refractory ulcerative colitis.Treatment of severe steroid refractory ulcerative colitis.What is the prognosis of ulcerative colitis?Treatment of choice for acute severe steroid-refractory ulcerative colitis is remicade.Therapeutic strategies for the management of ulcerative colitis.Therapeutic options in acute severe ulcerative colitis.Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease.Efficacy and safety of drugs for ulcerative colitis.The use of traditional and newer calcineurin inhibitors in inflammatory bowel disease.
P2860
Q26768280-271A86EF-1994-40E0-876B-7C07B701C2C5Q26777729-97AF1BDE-F06C-4827-BEF8-2450BD3FA426Q30502980-6981377B-4378-4023-B1D5-C634CCC50D24Q30664895-D84BA806-EFDF-4B51-B92A-15C5CC174183Q31004717-D2B6DA16-DFCB-4961-99F9-16D1E76D041CQ33268368-02A2F285-1C8E-4BAF-B7CD-FBF5FE4A8283Q33372802-BE55BBD0-8A81-4DE4-A5FC-867FECD4EC66Q33654733-210F1E5B-0D06-4363-A8B0-D9D1D146EDD6Q34025054-E64ED739-D4A8-4B6E-99BC-F9D2F65D77B7Q34225376-53D287A2-86CE-4041-8256-9D5782DFAA2AQ34449876-CEE0D5AE-6D0E-4161-BF41-0815D5AE76D8Q34484121-A2E58464-D7C4-4CA1-AB5E-AFEEB73B2B8AQ34647681-05445004-D1CA-4D64-AFAF-C9AEEF0C0236Q35100726-CC2F3C12-3591-4014-A608-2E381574A027Q35768958-65A1C0E6-A7B2-49DE-802F-0B24A8E9A813Q35841818-A94ED0B2-0FF1-450E-B047-404175E98B1AQ35883580-B534B383-E0E2-4B61-A3F0-410DD8DE540AQ36037115-BE3BEC6C-B2B9-48FA-BA79-4DBE8689FCCEQ36171733-B93968B0-04C1-4AB7-8F65-3F628D31A15DQ36305931-1378EE2B-5A6B-4CF3-AD92-43BFF66E6DCEQ36419073-A71C5D25-9C47-42C0-9A91-20464E763092Q36478109-894FC100-7720-4ED5-AC83-D3C799306CF7Q36580286-4CD570A7-0243-4B62-A810-66C5D27F551CQ36589437-E8712DEB-F30B-47E2-9E60-E308AD219BBFQ36637710-040B45BE-D820-46C4-B65F-EA4D13C4712FQ36745440-85EF5F46-E5D0-4206-B79C-97FE299A5781Q36948496-19757144-11C1-4586-9EAB-02EB668DA972Q37051414-E0F126D0-6861-4500-B240-5855196CF78FQ37141131-5DA8B346-525E-4785-A540-C84E75AB81E5Q37196938-D805CDBF-CE51-43B5-8CCD-BF635FFC28DDQ37226310-088545B8-8152-472F-8DB5-3C7419C85543Q37256032-704FA42F-3DD7-492E-9180-8A5D3E7F584CQ37276958-E074FFE3-4B97-4A48-B589-D8695238DC24Q37279167-F5BE6A23-CEDF-4188-84CE-6F0874F8CFC1Q37305793-B0B8217B-2980-4EC4-BB68-CE01B57CE943Q37318035-2B23E444-B2BC-417C-8074-5B9BB66E17C8Q37345935-BA63A3C0-6749-4173-AE64-0E99E4D5425FQ37701805-9207FA6A-7E3C-4A5C-A866-25B07C6FDA2BQ37727232-3EAA06CE-AF87-4B38-8367-D55AB7BAFD71Q37816246-DB03AD0D-5633-407F-AAC1-73F95ABC87D8
P2860
Long-term outcome of treatment with intravenous cyclosporin in patients with severe ulcerative colitis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Long-term outcome of treatment ...... ith severe ulcerative colitis.
@en
Long-term outcome of treatment ...... ith severe ulcerative colitis.
@nl
type
label
Long-term outcome of treatment ...... ith severe ulcerative colitis.
@en
Long-term outcome of treatment ...... ith severe ulcerative colitis.
@nl
prefLabel
Long-term outcome of treatment ...... ith severe ulcerative colitis.
@en
Long-term outcome of treatment ...... ith severe ulcerative colitis.
@nl
P2093
P2860
P50
P1476
Long-term outcome of treatment ...... ith severe ulcerative colitis.
@en
P2093
André D'Hoore
Freddy Penninckx
Geert D'Haens
Joris Arts
Martin Hiele
Miranda Zeegers
P2860
P356
10.1097/00054725-200403000-00002
P577
2004-03-01T00:00:00Z